Animal models and potential mechanisms of plaque destabilisation and disruption

Heart

Volumn 95, Issue 17, 2009, Pages 1393-1398

  Ni, M ^a   Chen, W Q ^a   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE CORONARY SYNDROME; ATHEROMA; ATHEROSCLEROTIC PLAQUE; EXPERIMENTAL ANIMAL; HEART INFARCTION; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLAQUE RUPTURE; PRIORITY JOURNAL; REVIEW; RUPTURE; SHEAR STRESS;

ACUTE CORONARY SYNDROME; ANIMALS; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; MICE; TERMINOLOGY AS TOPIC;

EID: 66749093801     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.143461     Document Type: Review

References (64)

1. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-72.
2. Fuster V, Badimon L, Badimon JJ, et al. The pathologenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med 1992;326:242-50.
3. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47:C7-12.
4. Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:C13-8.
5. Cullen P, Baetta R, Bellosta S, et al, MAFAPS Consortium. Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler Thromb Vasc Biol 2003;23:535-42.
6. Jackson CL, Bennett MR, Biessen EA, et al. Assessment of unstable atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007;27:714-20.
7. Hansson GK, Heistad DD. Two views on plaque rupture. Arterioscler Thromb Vasc Biol 2007;27:697.
8. Schwartz SM, Galis ZS, Rosenfeld ME, et al. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007;27:705-13.
9. Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003;41:15S-22.
10. Slager CJ, Wentzel JJ, Gijsen FJ, et al. The role of shear stress in the generation of rupture-prone vulnerable plaques. Nat Clin Pract Cardiovasc Med 2005;2:401-7.
11. Imoto K, Hiro T, Fujii T, et al. Longitudinal structural determinants of atherosclerotic plaque vulnerability: a computational analysis of stress distribution using vessel models and three-dimensional intravascular ultrasound imaging. J Am Coll Cardiol 2005;46:1507-15.
12. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75.
13. Burke AP, Kolodgie FD, Farb A, et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934-40.
14. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999;82:265-8.
15. Schaar JA, Muller JE, Falk E, et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 2004;25:1077-82.
16. Falk E, Schwartz SM, Galis ZS, et al. Putative murine models of plaque rupture. Arterioscler Thromb Vasc Biol 2007;27:969-72.
17. Chen WQ, Zhang L, Liu YF, et al. Prediction of atherosclerotic plaque ruptures with high frequency ultrasound imaging and serum inflammatory markers. Am J Physiol Heart Circ Physiol 2007;293:H2836-44.
18. Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999;99:3050-5.
19. Bouma BN, Meijers JC. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). J Thromb Haemost 2003;1:1566-74.
20. Te Velde EA, Wagenaar GT, Reijerkerk A, et al. Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost 2003;1:2087-96.
21. Von der Thusen JH, van Vlijmen BJ, Hoeben RC, et al. Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation 2002;105:2064-70.
22. Sasaki T, Kuzuya M, Nakamura K, et al. A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006;26:1304-9.
23. Lin HL, Xu XS, Lu HX, et al. Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques. J Mol Cell Cardiol 2007;43:272-80.
24. Pasterkamp G, Virmani R. The erythrocyte: a new player in atheromatous core formation. Heart 2002;88:115-6.
25. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-25.
26. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999;82:265-68.
27. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75.
28. Virmani R, Burke AP, Kolodgie FD, et al. Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol 2003;16:267-72.
29. Johnson J, Carson K, Williams H, et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 2005;111:1422-30.
30. Ni M, Zhang M, Ding SF, et al. Micro-ultrasound imaging assessment of carotid plaque characteristics in apolipoprotein-E knockout mice. Atherosclerosis 2008;197:64-71.
31. Kusumi Y, Scanu AM, McGill HC, et al. Atherosclerosis in a rhesus monkey with genetic hypercholesterolemia and elevated plasma Lp(a). Atherosclerosis 1993;99:165-74.
32. Nagasawa K, Tomoike H, Hayashi Y, et al. Intramural hemorrhage and endothelial changes in atherosclerotic coronary artery after repetitive episodes of spasm in x-ray-irradiated hypercholesterolemic pigs. Circ Res 1989;65:272-82.
33. Holvoet P, Theilmeier G, Shivalkar B, et al. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol 1998;18:415-22.
34. Prescott MF, McBride CH, Hasler-Rapacz J, et al. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 1991;139:139-47.
35. Granada JF, Moreno PR, Burke AP, et al. Endovascular needle injection of cholesteryl linoleate into the arterial wall produces complex vascular lesions identifiable by intravascular ultrasound: early development in a porcine model of vulnerable plaque. Coron Artery Dis 2005;16:217-24.
36. Constantinides P, Chakravarti RN. Rabbit arterial thrombosis production by systemic procedures. Arch Pathol 1961;72:197-208.
37. Abela GS, Picon PD, Friedl SE, et al. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation 1995;91:776-84.
38. Nakamura M, Abe S, Kinukawa N. Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II. Atherosclerosis 1997;128:149-56.
39. Rekhter MD, Hicks GW, Brammer DW, et al. Animal model that mimics atherosclerotic plaque rupture. Circ Res 1998;83:705-13.
40. Reddick RL, Zhang SH, Maeda N. Aortic atherosclerotic plaque injury in apolipoprotein E deficient mice. Atherosclerosis 1998;140:297-305.
41. Chiesa G, Di Mario C, Colombo N, et al. Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound. Atherosclerosis 2001;156:277-87.
42. Pakala R, Leborgne L, Cheneau E, et al. Radiation-induced atherosclerotic plaque progression in a hypercholesterolemic rabbit: a prospective vulnerable plaque model? Cardiovasc Radiat Med 2003;4:146-51.
43. Leborgne L, Pakala R, Dilcher C, et al. Effect of antioxidants on atherosclerotic plaque formation in balloon-denuded and irradiated hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2005;46:540-7.
44. Levy AP, Moreno PR. Intraplaque hemorrhage. Curr Mol Med 2006;6:479-88.
45. Jawień J, Nastałek P, Korbut R. Mouse models of experimental atherosclerosis. J Physiol Pharmacol 2004;55:503-17.
46. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
47. De Nooijer R, von der Thüsen JH, Verkleij CJ, et al. Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol 2004;24:2313-9.
48. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
49. Galis ZS, Sukhova GK, Kranzhofer R, et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995;92:402-6.
50. De Nooijer R, Verkleij CJ, von der Thüsen JH, et al. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol 2006;26:340-6.
51. Gough PJ, Gomez IG, Wille PT, et al. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 2006;116:59-69.
52. Zadelaar AS, Thusen JH, M Boesten LS, et al. Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer. Atherosclerosis 2005;183:244-50.
53. Mazzolai L, Duchosal MA, Korber M, et al. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice. Hypertension 2004;44:277-82.
54. Da Cunha V, Martin-McNulty B, Vincelette J, et al. Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis. J Vasc Surg 2006;44:364-71.
55. Hemdahl AL, Caligiuri G, Hansson GK, et al. Electrocardiographic characterization of stress-induced myocardial infarction in atherosclerotic mice. Acta Physiol Scand 2005;184:87-94.
56. Hemdahl AL, Falk E, Thorén P, et al. Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice. Am J Physiol Heart Circ Physiol 2004;287:H872-7.
57. Cheng C, Tempel D, van Haperen R, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006;113:2744-53.
58. Mattsson EJ, Kohler TR, Vergel SM, et al. Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Biol 1997;17:2245-9.
59. Slager CJ, Wentzel JJ, Gijsen FJ, et al. The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovasc Med 2005;2:456-64.
60. Eren M, Painter CA, Atkinson JB, et al. Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation 2002;106:491-6.
61. Calara F, Silvestre M, Casanada F, et al. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptordeficient mice. J Pathol 2001;195:257-63.
62. Rosenfeld ME, Polinsky P, Virmani R, et al. Advanced atherosclerotic lesions in innominate artery of apoE knockout mouse. Arterioscler Thromb Vasc Biol 2000;20:2587-92.
63. Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 2001;154:399-406.
64. Williams H, Johnson JL, Carson KG, et al. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2002;22:788-92.